Clinical trial
A Study Investigating Safety, Tolerability and Efficacy of UBT251 in Participants Living With Overweight or Obesity
NCT07395687 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Investigating Safety, Tolerability and Efficacy of UBT251 in Participants Living With Overweight or Obesity
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 2, 2026
- Completion date
- February 18, 2027
- Enrollment
- 333 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.